Kura Oncology Cash Flow Statement (2024-2025) | KURA

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M
Depreciation and Depletion 0.23M0.20M0.21M0.20M0.24M0.22M0.16M
Share-based Compensation 8.51M8.43M8.32M8.63M7.84M6.95M10.96M
Gains from Investment Securities 0.70M1.16M1.16M0.97M
Non-cash Items 49.40M49.00M47.20M7.71M47.20M43.70M41.00M
Cash from Operations -48.84M-42.53M-43.44M269.13M-71.93M-28.78M-80.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 3.27M3.55M3.44M2.88M2.66M2.52M1.92M
Amortization of Deferred Charges 0.12M0.13M0.13M0.14M0.13M0.14M0.14M
Depreciation & Amortization (CF) 0.23M0.20M0.21M0.20M0.24M0.22M0.16M
Change in Working Capital
Change in Receivables 46.69M-44.17M31.36M
Change in Accured Expenses -3.13M-0.05M5.68M12.70M-5.43M7.53M12.72M
Investing Activities
Capital Expenditures 0.08M0.02M0.37M0.29M1.46M2.57M
Change in Acquisitions & Divestments 99.81M204.86M107.26M146.00M167.60M175.00M235.03M
Cash from Investing Activities -95.34M43.17M45.53M-94.95M-101.41M58.94M93.97M
Financing Activities
Other financing activities 2.56M3.04M2.20M0.81M0.14M0.52M
Change in Capital Stock
Shares Issued 2.56M3.04M2.20M0.81M0.14M0.52M
Misc.
Cash from Financing Activities 148.37M3.04M2.20M0.81M0.14M0.52M
Change in Cash 4.19M3.68M4.30M174.98M-173.19M30.68M13.34M
Beginning Cash Balance 37.32M41.51M45.18M49.48M224.46M51.27M81.95M
Free Cash Flow -48.93M-42.55M-43.44M268.76M-72.22M-30.23M-83.19M
Net Cash Flow 4.19M3.68M4.30M174.98M-173.19M30.68M13.34M